Whitehawk Therapeutics, Inc. (WHWK) Return on equity 2018–2025
Whitehawk Therapeutics, Inc. (WHWK) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-15.1%FY2025 · since FY2018: -17.7% → -15.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -15.1% | +106.3 pp |
| FY2024 | -121.4% | -58.8 pp |
| FY2023 | -62.5% | -24.3 pp |
| FY2022 | -38.2% | +42.5 pp |
| FY2021 | -80.7% | — |
| FY2018 | -17.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice